http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35918422

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 108
issn 1432-1912
0028-1298
issueIdentifier 1
pageRange 99-108
publicationName Naunyn-Schmiedeberg's Archives of Pharmacology
startingPage 99
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a300e35772459d2f6e8a8482a7553bc
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_bfd0e6912e1a0ebf2534c831dfb49332
bibliographicCitation Chen L, Gong P, Su Y, Meng L, Wang M, Gao W, Liu Q. Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming. Naunyn Schmiedebergs Arch Pharmacol. 2024 Jan;397(1):99–108. doi: 10.1007/s00210-023-02589-0. PMID: 37368029.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f6a77a085f6d33d3fbadb1efc89c215
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b5057fbc1ed3648b287467d6dc8d3fd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b1261d4aad9cd47ec8c00e6f82ad0c62
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5b15f7bf7502e37f27d0aee3f10e253f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c981cd8a8d30dc6b7f007f903b03d691
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fe8cffbbd4d491a22157074a42d5f52b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce
date 2023-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/37368029
https://doi.org/10.1007/s00210-023-02589-0
isPartOf https://portal.issn.org/resource/ISSN/0028-1298
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/6017
https://portal.issn.org/resource/ISSN/1432-1912
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Angiotensin II type 2 receptor agonist attenuates LPS-induced acute lung injury through modulating THP-1-derived macrophage reprogramming
discusses http://id.nlm.nih.gov/mesh/M000741785
http://id.nlm.nih.gov/mesh/M0012577
http://id.nlm.nih.gov/mesh/M0261994
http://id.nlm.nih.gov/mesh/M0024747
http://id.nlm.nih.gov/mesh/M0024955
http://id.nlm.nih.gov/mesh/M0024272
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57953977
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15559608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24180873
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9082
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45029742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442514
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9077

Total number of triples: 51.